307 related articles for article (PubMed ID: 20045715)
1. Improvement of cathepsin S detection using a designed FRET peptide based on putative natural substrates.
Oliveira M; Torquato RJ; Alves MF; Juliano MA; Brömme D; Barros NM; Carmona AK
Peptides; 2010 Apr; 31(4):562-7. PubMed ID: 20045715
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and hydrolysis by cysteine and serine proteases of short internally quenched fluorogenic peptides.
Melo RL; Alves LC; Del Nery E; Juliano L; Juliano MA
Anal Biochem; 2001 Jun; 293(1):71-7. PubMed ID: 11373081
[TBL] [Abstract][Full Text] [Related]
3. S1 subsite specificity of a recombinant cysteine proteinase, CPB, of Leishmania mexicana compared with cruzain, human cathepsin L and papain using substrates containing non-natural basic amino acids.
Alves LC; Melo RL; Sanderson SJ; Mottram JC; Coombs GH; Caliendo G; Santagada V; Juliano L; Juliano MA
Eur J Biochem; 2001 Mar; 268(5):1206-12. PubMed ID: 11231271
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human cathepsin X is a carboxymonopeptidase only: a comparison with cathepsins B and L.
Puzer L; Cotrin SS; Cezari MH; Hirata IY; Juliano MA; Stefe I; Turk D; Turk B; Juliano L; Carmona AK
Biol Chem; 2005 Nov; 386(11):1191-5. PubMed ID: 16307485
[TBL] [Abstract][Full Text] [Related]
5. Probing the specificity of cysteine proteinases at subsites remote from the active site: analysis of P4, P3, P2' and P3' variations in extended substrates.
Portaro FC; Santos AB; Cezari MH; Juliano MA; Juliano L; Carmona E
Biochem J; 2000 Apr; 347 Pt 1(Pt 1):123-9. PubMed ID: 10727410
[TBL] [Abstract][Full Text] [Related]
6. Defining the substrate specificity of mouse cathepsin P.
Puzer L; Barros NM; Oliveira V; Juliano MA; Lu G; Hassanein M; Juliano L; Mason RW; Carmona AK
Arch Biochem Biophys; 2005 Mar; 435(1):190-6. PubMed ID: 15680921
[TBL] [Abstract][Full Text] [Related]
7. Probing cathepsin K activity with a selective substrate spanning its active site.
Lecaille F; Weidauer E; Juliano MA; Brömme D; Lalmanach G
Biochem J; 2003 Oct; 375(Pt 2):307-12. PubMed ID: 12837132
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen hydrolysis by cathepsin S and identification of derived peptides as selective substrate for cathepsin V and cathepsin L inhibitor.
Coppini LP; Barros NM; Oliveira M; Hirata IY; Alves MF; Paschoalin T; Assis DM; Juliano MA; Puzer L; Brömme D; Carmona AK
Biol Chem; 2010 May; 391(5):561-70. PubMed ID: 20302511
[TBL] [Abstract][Full Text] [Related]
9. Comparative substrate specificity analysis of recombinant human cathepsin V and cathepsin L.
Puzer L; Cotrin SS; Alves MF; Egborge T; Araújo MS; Juliano MA; Juliano L; Brömme D; Carmona AK
Arch Biochem Biophys; 2004 Oct; 430(2):274-83. PubMed ID: 15369827
[TBL] [Abstract][Full Text] [Related]
10. Conserved cystatin segments as models for designing specific substrates and inhibitors of cysteine proteinases.
Lalmanach G; Serveau C; Brillard-Bourdet M; Chagas JR; Mayer R; Juliano L; Gauthier F
J Protein Chem; 1995 Nov; 14(8):645-53. PubMed ID: 8747425
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory fragment from the p41 form of invariant chain can regulate activity of cysteine cathepsins in antigen presentation.
Mihelic M; Dobersek A; Guncar G; Turk D
J Biol Chem; 2008 May; 283(21):14453-60. PubMed ID: 18362148
[TBL] [Abstract][Full Text] [Related]
12. Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages.
Shi GP; Bryant RA; Riese R; Verhelst S; Driessen C; Li Z; Bromme D; Ploegh HL; Chapman HA
J Exp Med; 2000 Apr; 191(7):1177-86. PubMed ID: 10748235
[TBL] [Abstract][Full Text] [Related]
13. S3 to S3' subsite specificity of recombinant human cathepsin K and development of selective internally quenched fluorescent substrates.
Alves MF; Puzer L; Cotrin SS; Juliano MA; Juliano L; Brömme D; Carmona AK
Biochem J; 2003 Aug; 373(Pt 3):981-6. PubMed ID: 12733990
[TBL] [Abstract][Full Text] [Related]
14. Cathepsin S, but not cathepsin L, participates in the MHC class II-associated invariant chain processing in large yellow croaker (Larimichthys crocea).
Li Q; Ao J; Mu Y; Yang Z; Li T; Zhang X; Chen X
Fish Shellfish Immunol; 2015 Dec; 47(2):743-50. PubMed ID: 26475363
[TBL] [Abstract][Full Text] [Related]
15. Invariant chain processing is independent of cathepsin variation between primary human B cells/dendritic cells and B-lymphoblastoid cells.
Reich M; Zou F; Sieńczyk M; Oleksyszyn J; Boehm BO; Burster T
Cell Immunol; 2011; 269(2):96-103. PubMed ID: 21543057
[TBL] [Abstract][Full Text] [Related]
16. Carboxydipeptidase activities of recombinant cysteine peptidases. Cruzain of Trypanosoma cruzi and CPB of Leishmania mexicana.
Judice WA; Puzer L; Cotrin SS; Carmona AK; Coombs GH; Juliano L; Juliano MA
Eur J Biochem; 2004 Mar; 271(5):1046-53. PubMed ID: 15009216
[TBL] [Abstract][Full Text] [Related]
17. Human cathepsin X: A cysteine protease with unique carboxypeptidase activity.
Nägler DK; Zhang R; Tam W; Sulea T; Purisima EO; Ménard R
Biochemistry; 1999 Sep; 38(39):12648-54. PubMed ID: 10504234
[TBL] [Abstract][Full Text] [Related]
18. Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis.
Tolosa E; Li W; Yasuda Y; Wienhold W; Denzin LK; Lautwein A; Driessen C; Schnorrer P; Weber E; Stevanovic S; Kurek R; Melms A; Bromme D
J Clin Invest; 2003 Aug; 112(4):517-26. PubMed ID: 12925692
[TBL] [Abstract][Full Text] [Related]
19. Identification of putative cathepsin S in mangrove red snapper Lutjanus argentimaculatus and its role in antigen presentation.
Zhou J; Li L; Cai ZH
Dev Comp Immunol; 2012 May; 37(1):28-38. PubMed ID: 22210546
[TBL] [Abstract][Full Text] [Related]
20. Discrimination of cruzipain, the major cysteine proteinase of Trypanosoma cruzi, and mammalian cathepsins B and L, by a pH-inducible fluorogenic substrate of trypanosomal cysteine proteinases.
Serveau C; Lalmanach G; Hirata I; Scharfstein J; Juliano MA; Gauthier F
Eur J Biochem; 1999 Jan; 259(1-2):275-80. PubMed ID: 9914503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
